Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
D000328:Adult; D000368:Aged; D002496:Central Venous Pressure; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005934:Glucagon / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009638:Norepinephrine / Q000627:therapeutic use*; D010646:Phentolamine / Q000627:therapeutic use*; D011379:Prognosis; D013902:Radiography, Thoracic; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality
D004071:Digitalis Glycosides; D004338:Drug Combinations; D008680:Metaraminol; D005934:Glucagon; D009638:Norepinephrine; D010646:Phentolamine